SCHEMBL2222595

SCHEMBL2222595

COc1ccc2[nH]cc(S(=O)(=O)c3ccc(C(F)(F)F)c(NC4CCN(C)CC4)c3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TP53 P04637 1/20 0.44
KCNH2 Q12809 2/20 0.39
EZH2 Q15910 2/20 0.39
HTR6 P50406 3/20 0.38
CYP3A4 P08684 3/20 0.37
DRD2 P14416 2/20 0.37
SLC6A2 P23975 2/20 0.37
HTR2A P28223 2/20 0.37
HTR2C P28335 2/20 0.37
HTR7 P34969 2/20 0.37
HRH1 P35367 2/20 0.37
ADRA1B P35368 2/20 0.37
SLC6A3 Q01959 2/20 0.37
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
CYP2D6 P10635 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2220948 0.93 MAPT (0.41) MAPTLMNAHTTSMN1; SMN2TP53
SCHEMBL2223438 0.90 MAPT (0.53) MAPTLMNAHTTSMN1; SMN2TP53
SCHEMBL2226273 0.88 MAPT (0.48) MAPTLMNAHTTSMN1; SMN2TP53
SCHEMBL2224849 0.88 CYP3A4 (0.43) KCNH2HTR6CYP3A4DRD2SLC6A2
SCHEMBL2223322 0.88 MAPT (0.53) MAPTLMNAHTTSMN1; SMN2TP53
SCHEMBL2223312 0.88 MAPT (0.56) MAPTLMNAHTTSMN1; SMN2TP53
SCHEMBL2222361 0.88 MAPT (0.53) MAPTLMNAHTTSMN1; SMN2TP53
Hydrochloric Acid SCHEMBL2223353 0.86 MAPT (0.52) MAPTLMNAHTTSMN1; SMN2TP53
SCHEMBL2221872 0.83 KCNH2 (0.42) KCNH2HTR6CYP3A4
SCHEMBL2226307 0.83 KCNH2 (0.49) MAPTKCNH2HTR6CYP3A4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A MAPT 509/4885LMNA 3622/4885HTT 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.